Patient-specific vascularized tumor model: Blocking monocyte recruitment with multispecific antibodies targeting CCR2 and CSF-1R
Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma
In vitro integration of a functional vasculature to model endothelial regulation of chemotherapy and T-cell immunotherapy in liver cancer
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
Immune targeting of triple-negative breast cancer through a clinically actionalbe STING agonist-CART cell platform
